newsfilter
← Latest News
Business Wire·

Pear Therapeutics to Issue First Quarter 2022 Financial Results on Monday, May 16, 2022

Pear Therapeutics, Inc. (NASDAQ:PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that the company will issue its first quarter 2022 financial results after the